Primary Extrapulmonary Small Cell Carcinoma of the Appendix - A Case Report -
0
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Primary extrapulmonary small cell carcinoma (EPSCC) of the appendix is an extremely rare entity, and there has been only one previous report on this in the English medical literature. We report here on the first Korean case of EPSCC of the appendix in a 55-year-old woman. The patient had no history of an identified pulmonary tumor, and she presented with constipation and lower abdominal pain. The patient underwent right hemicolectomy with regional lymph node dissection and bilateral salphigo-oophorectomy. The histology of the entire appendiceal tumor revealed pure EPSCC with diffuse immunoreactivity for pancytokeratin, cytokeratin 7, cytokeratin 20, CD56, thyroid transcription factor 1, c-kit and carcinoembryonic antigen, and there was focal weak immunoreactivity for chromogranin A and synaptophysin. After the second cycle of chemotherapy, the condition of the patient gradually deteriorated due to cancer peritonei and the patient died 7 months later. EPSCC of the appendix is a distinctive clinicopathological entity that displays highly aggressive behavior and an unfavorable outcome.
Abstract
Primary extrapulmonary small cell carcinoma (EPSCC) of the appendix is an extremely rare entity, and there has been only one previous report on this in the English medical literature. We report here on the first Korean case of EPSCC of the appendix in a 55-year-old woman. The patient had no history of an identified pulmonary tumor, and she presented with constipation and lower abdominal pain. The patient underwent right hemicolectomy with regional lymph node dissection and bilateral salphigo-oophorectomy. The histology of the entire appendiceal tumor revealed pure EPSCC with diffuse immunoreactivity for pancytokeratin, cytokeratin 7, cytokeratin 20, CD56, thyroid transcription factor 1, c-kit and carcinoembryonic antigen, and there was focal weak immunoreactivity for chromogranin A and synaptophysin. After the second cycle of chemotherapy, the condition of the patient gradually deteriorated due to cancer peritonei and the patient died 7 months later. EPSCC of the appendix is a distinctive clinicopathological entity that displays highly aggressive behavior and an unfavorable outcome.
참고문헌 (12)
- Rossi G, "Primary mixed adenocarcinoma and small cell carcinoma of the appendix:a clinicopathologic,immunohistochemical,and molecular study of a hitherto unreported tumor", Am J Surg Pathol, 28, pp.1233~1239 (2004)
- O’Kane AM, "Small cell carcinoma of the appendix", World J Surg Oncol, 6, pp.1~4 (2008)
- McCusker ME, "Primary malignant neoplasms of the appendix:a population-based study from the surveillance,epidemiology and end-results program,1973-1998", Cancer, 94, pp.3307~3312 (2002)
- Duguid JB, "Oat-cell tumors of mediastinal glands", J Pathol Bacteriol, 33, pp.93~99 (1930)
- Cicin I, "Extrapulmonary small-cell carcinoma compared with small-cell lung carcinoma:a retrospective single-center study", Cancer, 110, pp.1068~1076 (2007)
- Lee SS, "Extrapulmonary small cell carcino-ma:single center experience with 61 patients", Acta Oncol, 46, pp.846~851 (2007)
- Bernick PE, "Neuroendocrine carcinomas of the colon and rectum", Dis Colon Rectum, 47, pp.163~169 (2004)
- Demellawy DE, "Primary small cell carcinoma of the cecum", Ann Diagn Pathol, 10, pp.162~165 (2006)
- Vortmeyer AO, "Concordance of genetic alterations in poorly differentiated colorectal neuroendocrine carcinomas and associated adenocarcinomas", J Natl Cancer Inst, 89, pp.1448~1453 (1997)
- de Bruin NC, "Small-cell undifferentiated(neuroendocrine)carcinoma of the cecum in a child with common variable immunodeficiency", Am J Pediatr Hematol Oncol, 15, pp.258~261 (1993)
- Werling RW, "CDX2,a highly sensitive and specific marker of adenocarcinomas of intestinal origin:an immunohistochemical survey of 476 primary and metastatic carcinomas", Am J Surg Pathol, 27, pp.303~310 (2003)
- Kurt E, "Therapy,outcome and analysis of c-kit expression in patients with extrapulmonary small cell carcinoma", Int J Clin Pract, 59, pp.537~543 (2005)